Vanilloid receptor 1(VR1) is expressed by sensory neurons. Once activated,
these neurons evoke the sensation of burning pain and release neuropeptides
that induce neurogenic Inflammation. We used immunoblotting and immunostai
ning to estimate the density of VR1 in colonic tissues of patients with inf
lammatory bowel disease and of controls. Our study results indicate that VR
1 immunoreactivity is greatly increased in colonic nerve fibres of patients
with active inflammatory bowel disease. Thus, the discovery of new drugs t
hat can bind the VRI receptor, or antagonise endogenous inflammatory substa
nces that activate this receptor, could lead to new therapies for pain and
dysmotility.